Preliminary analysis of a phase 1/2 study of NEXI-001 donor-derived multi-antigen-specific CD8(+) T-cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT) Meeting Abstract
| Authors: | Al Malki, M.; Vasu, S.; Modi, D.; Perales, M. A.; Bui, D.; Edavana, V.; Kim, S.; Suarez, L.; Oelke, M.; Bednárik, D.; Knight, R. D.; Varela, J. C. |
| Abstract Title: | Preliminary analysis of a phase 1/2 study of NEXI-001 donor-derived multi-antigen-specific CD8(+) T-cells for the treatment of relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic cell transplantation (HCT) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601060 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2538 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2538 -- Source: Wos |
